Clinical Trial Update: A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

View source ↗

Summary

A clinical trial is evaluating the safety of exposure to Wegovy (semaglutide) during pregnancy, with enrollment ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Pregnancy

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Pregnancy, Obesity | Status: ENROLLING_BY_INVITATION